药品名称NAPROSYN
申请号017581产品号004
活性成分NAPROXEN市场状态处方药
剂型或给药途径TABLET;ORAL规格500MG
治疗等效代码AB参比药物
批准日期1982/04/15申请机构ATNAHS PHARMA US LTD
化学类型New molecular entity (NME)审评分类Standard review drug
与本品相关的专利信息(来自橙皮书Orange Book)
专利号专利过期日是否化合物专利是否产品专利专利用途代码专利下载
历史专利信息
与本品相关的市场独占权保护信息
独占权代码失效日期
历史市场独占权保护信息
与药品注册相关的信息
申请号修订号审批结论公开文档类型文档创建时间获取文档
017581112APLetter2016/05/11下载
017581112APLabel2016/05/11下载
017581111APLabel2013/03/26下载
017581111APLetter2013/03/26下载
017581110APLabel2008/07/29下载
017581110APLetter2008/07/30下载
017581108APLetter2007/09/25下载
017581108APLabel2007/09/26下载
017581107APLetter2007/04/25下载
017581106APLabel2006/01/25下载
017581106APLetter2006/01/30下载
017581105APLabel2006/03/14下载
017581105APLetter2006/03/23下载
017581100APLetter2004/11/16下载
017581100APLabel2004/11/16下载
017581099APLabel2004/11/16下载
017581099APLetter2004/11/16下载
017581098APLetter2003/05/29下载
017581004APReview2007/04/11下载
017581000APMedication Guide2009/11/19下载
药品注册审批历史信息
申请号修订号审批结论审批日期审批内容
017581112AP2016/05/09Labeling Revision
017581111AP2013/03/22Labeling Revision
017581110AP2008/07/25Labeling Revision
017581108AP2007/09/20Labeling Revision
017581107AP2007/04/19Labeling Revision
017581106AP2006/01/24Labeling Revision
017581105AP2006/03/10Labeling Revision
017581103AP2002/02/22Manufacturing Change or Addition
017581102AP2001/11/09Package Change
017581101AP2000/12/08Manufacturing Change or Addition
017581100AP2004/11/10Labeling Revision
017581099AP2004/11/10Labeling Revision
017581098AP2003/04/14Labeling Revision
017581097AP1994/12/08Manufacturing Change or Addition
017581096AP1994/03/28Package Change
017581095AP1994/09/12Control Supplement
017581093AP1992/08/12Manufacturing Change or Addition
017581089AP1992/05/08Package Change
017581088AP1991/09/16Package Change
017581087AP1994/04/21Package Change
017581086AP1991/10/30Control Supplement
017581080AP1989/04/21Formulation Revision
017581073AP1987/03/23New or Modified Indication
017581072AP1986/12/16Labeling Revision
017581069AP1985/09/24Labeling Revision
017581068AP1986/06/10Package Change
017581067AP1986/07/17Control Supplement
017581065AP1987/03/23New Dosage Regimen
017581064AP1985/04/23Manufacturing Change or Addition
017581063AP1986/12/16Formulation Revision
017581062AP1985/04/23Manufacturing Change or Addition
017581060AP1985/04/29Manufacturing Change or Addition
017581054AP1983/09/09Labeling Revision
017581053AP1985/04/23Control Supplement
017581051AP1988/02/18Manufacturing Change or Addition
017581050AP1982/12/03Labeling Revision
017581049AP1982/12/03Labeling Revision
017581048AP1983/01/13Control Supplement
017581046AP1983/09/09Labeling Revision
017581045AP1982/03/31Manufacturing Change or Addition
017581044AP1982/03/31Manufacturing Change or Addition
017581043AP1981/12/21Package Change
017581042AP1982/01/07Package Change
017581041AP1981/10/13Control Supplement
017581040AP1981/10/13Control Supplement
017581039AP1981/10/13Control Supplement
017581038AP1982/01/08Package Change
017581037AP1981/04/02Control Supplement
017581036AP1981/10/13Formulation Revision
017581034AP1981/04/13Labeling Revision
017581033AP1981/10/13Labeling Revision
017581031AP1982/04/15Labeling Revision
017581030AP1980/09/12Labeling Revision
017581027AP1980/05/13Labeling Revision
017581026AP1980/03/21Control Supplement
017581024AP1980/04/14Formulation Revision
017581020AP1979/07/09Control Supplement
017581019AP1979/07/09Package Change
017581018AP1979/09/06Manufacturing Change or Addition
017581017AP1979/07/17Control Supplement
017581015AP1979/02/15Control Supplement
017581013AP1979/02/15Control Supplement
017581012AP1979/06/07Manufacturing Change or Addition
017581011AP1978/05/02Manufacturing Change or Addition
017581010AP1979/05/24Control Supplement
017581009AP1978/11/27Control Supplement
017581007AP1978/08/04Control Supplement
017581006AP1979/05/02Package Change
017581005AP1979/05/02Package Change
017581004AP1980/07/15Manufacturing Change or Addition
017581003AP1976/11/29Manufacturing Change or Addition
017581002AP1976/05/13Labeling Revision
017581001AP1980/07/15General Efficacy (MarkIV)
017581000AP1976/03/11Approval